Use of Ibandronate in Diabetic Patients

NCT05266261 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

121

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis, Postmenopausal
Type 2 Diabetes

Interventions

DRUG: Ibandronate Oral Tablet

Sponsor

Yeouido St. Mary's Hospital

Collaborators

[object Object]
[object Object]